Recent News
-
Symposium’23 Program
Program here.
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies”, March 17, 2023, 13:30 -
3e matinée Carnot Star “9-12 Recherche-Industrie” dédiée à l’Imagerie, 17 Mars 2023, 8h30
Programme ici, inscriptions ici, . -
FairEmbo en Afrique : “Ce médecin marseillais sauve des femmes avec des bouts de ficelle”
FairEmbo en Afrique : l’Embolisation-pour-tous franchit une nouvelle étape. Plus d’informations ici. -
Webinar: Discover Radiotheranostics in Nuclear Medicine (15 Sept. 2022)
Plus d’informations ici. -
Le projet EmboBio, développé au CERIMED, a reçu le prix de l’innovation AP-HM 2022
Plus d’informations sur le prix AP-HM de l’innovation 2022 ici. Plus d’informations sur le projet Embobio dans cette vidéo. -
Le CERIMED obtient la double certification ISO 9001:2015 et NF X50-900:2016 pour ses activités de prestation et d’innovation radiologiques et nucléaires pré-cliniques
Le Centre Européen de Recherche en Imagerie Médicale (CERIMED, UMS AMU CNRS 2012) a obtenu le 5 juin 2022 la double certification ISO 9001:2015 et NF-X50-900:2016 pour -
Symposium’21 Program
Program here.
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies” -
VECT-HORUS and CERIMED Announce Collaboration to Support the Development of VECT-HORUS’ Theragnostic Agents
VECT-HORUS, a biotechnology company that designs and develops vectors that facilitate the targeted delivery of therapeutic molecules and imaging agents, has announced the signing of a collaboration -
FAIR-Embo hopes to spread safe, cheap embolization around the world
We are proud to anounce that Pr Vincent Vidal (Marseille, France), Head of the Experimental Interventional Radiology Laboratory hosted at CERIMED, and colleagues have demonstrated the in vivo feasibility
Last Publications (10/391)
- Bobot, M, Guedj, E, Resseguier, N, Faraut, J, Garrigue, P, Nail, V et al.. Increased Blood-Brain Barrier Permeability and Cognitive Impairment in Patients With ESKD. Kidney Int Rep. 2024;9 (10):2988-2995. doi: 10.1016/j.ekir.2024.07.021. PubMed PMID:39430169 PubMed Central PMC11489453.
- Flaus, A, Guedj, E, Horowitz, T, Semah, F, Verger, A, Hammers, A et al.. Brain PET Imaging in the Presurgical Evaluation of Drug-Resistant Focal Epilepsy. PET Clin. 2024; :. doi: 10.1016/j.cpet.2024.09.008. PubMed PMID:39426849 .
- Arbizu, J, Morbelli, S, Minoshima, S, Barthel, H, Kuo, P, Van Weehaeghe, D et al.. SNMMI Procedure Standard/EANM Practice Guideline for Brain [18F]FDG PET Imaging, Version 2.0. J Nucl Med. 2024; :. doi: 10.2967/jnumed.124.268754. PubMed PMID:39419552 .
- Agripnidis, T, Ruimy, A, Panneau, J, Nguyen, J, Nail, V, Tradi, F et al.. In Vivo Feasibility of Arterial Embolization with a New Permanent Agar-agar-Based Agent. Cardiovasc Intervent Radiol. 2024; :. doi: 10.1007/s00270-024-03877-9. PubMed PMID:39402417 .
- Wagner, CA, Massy, ZA, Capasso, G, Mattace-Raso, F, Pepin, M, Bobot, M et al.. Translational research on cognitive impairment in chronic kidney disease. Nephrol Dial Transplant. 2024; :. doi: 10.1093/ndt/gfae229. PubMed PMID:39400744 .
- Guedj, E, Newberg, A, Høilund-Carlsen, PF, Alavi, A. Innovations and Future Directions in Brain PET Imaging: Pioneering a New Era in Personalized Medicine. PET Clin. 2024; :. doi: 10.1016/j.cpet.2024.09.011. PubMed PMID:39366799 .
- Cortez, BN, Kuo, MJM, Jha, A, Patel, M, Carrasquillo, JA, Prodanov, T et al.. Case Series: ATRX Variants in Four Patients with Metastatic Pheochromocytoma. Front Endocrinol (Lausanne). 2024;15 :1399847. doi: 10.3389/fendo.2024.1399847. PubMed PMID:39351526 PubMed Central PMC11439680.
- Nail, V, Chapot, A, Nachar, O, Gabriel, S, Moyon, A, Taieb, D et al.. Medication reconciliation enhances the accuracy of gastric emptying scintigraphy. EJNMMI Radiopharm Chem. 2024;9 (1):68. doi: 10.1186/s41181-024-00299-3. PubMed PMID:39325280 PubMed Central PMC11427626.
- Taïeb, D, Deandreis, D, Hicks, RJ. Reimagining Biologically Adapted Somatostatin Receptor-Targeted Radionuclide Therapy: Perspectives Based on Personal Experience and Observations on Recent Trials. J Nucl Med. 2024; :. doi: 10.2967/jnumed.124.268136. PubMed PMID:39299784 .
- Horowitz, T, Grimaldi, S, Dufour, H, Graillon, T, Azulay, JP, Guedj, E et al.. 18F-FDG brain PET: a metabolic predictive factor for gait improvement after cerebrospinal fluid shunting in normal pressure hydrocephalus?. Q J Nucl Med Mol Imaging. 2024;68 (3):179-186. doi: 10.23736/S1824-4785.24.03582-9. PubMed PMID:39295448 .
Dernières Publications (10/391)
- Bobot, M, Guedj, E, Resseguier, N, Faraut, J, Garrigue, P, Nail, V et al.. Increased Blood-Brain Barrier Permeability and Cognitive Impairment in Patients With ESKD. Kidney Int Rep. 2024;9 (10):2988-2995. doi: 10.1016/j.ekir.2024.07.021. PubMed PMID:39430169 PubMed Central PMC11489453.
- Flaus, A, Guedj, E, Horowitz, T, Semah, F, Verger, A, Hammers, A et al.. Brain PET Imaging in the Presurgical Evaluation of Drug-Resistant Focal Epilepsy. PET Clin. 2024; :. doi: 10.1016/j.cpet.2024.09.008. PubMed PMID:39426849 .
- Arbizu, J, Morbelli, S, Minoshima, S, Barthel, H, Kuo, P, Van Weehaeghe, D et al.. SNMMI Procedure Standard/EANM Practice Guideline for Brain [18F]FDG PET Imaging, Version 2.0. J Nucl Med. 2024; :. doi: 10.2967/jnumed.124.268754. PubMed PMID:39419552 .
- Agripnidis, T, Ruimy, A, Panneau, J, Nguyen, J, Nail, V, Tradi, F et al.. In Vivo Feasibility of Arterial Embolization with a New Permanent Agar-agar-Based Agent. Cardiovasc Intervent Radiol. 2024; :. doi: 10.1007/s00270-024-03877-9. PubMed PMID:39402417 .
- Wagner, CA, Massy, ZA, Capasso, G, Mattace-Raso, F, Pepin, M, Bobot, M et al.. Translational research on cognitive impairment in chronic kidney disease. Nephrol Dial Transplant. 2024; :. doi: 10.1093/ndt/gfae229. PubMed PMID:39400744 .
- Guedj, E, Newberg, A, Høilund-Carlsen, PF, Alavi, A. Innovations and Future Directions in Brain PET Imaging: Pioneering a New Era in Personalized Medicine. PET Clin. 2024; :. doi: 10.1016/j.cpet.2024.09.011. PubMed PMID:39366799 .
- Cortez, BN, Kuo, MJM, Jha, A, Patel, M, Carrasquillo, JA, Prodanov, T et al.. Case Series: ATRX Variants in Four Patients with Metastatic Pheochromocytoma. Front Endocrinol (Lausanne). 2024;15 :1399847. doi: 10.3389/fendo.2024.1399847. PubMed PMID:39351526 PubMed Central PMC11439680.
- Nail, V, Chapot, A, Nachar, O, Gabriel, S, Moyon, A, Taieb, D et al.. Medication reconciliation enhances the accuracy of gastric emptying scintigraphy. EJNMMI Radiopharm Chem. 2024;9 (1):68. doi: 10.1186/s41181-024-00299-3. PubMed PMID:39325280 PubMed Central PMC11427626.
- Taïeb, D, Deandreis, D, Hicks, RJ. Reimagining Biologically Adapted Somatostatin Receptor-Targeted Radionuclide Therapy: Perspectives Based on Personal Experience and Observations on Recent Trials. J Nucl Med. 2024; :. doi: 10.2967/jnumed.124.268136. PubMed PMID:39299784 .
- Horowitz, T, Grimaldi, S, Dufour, H, Graillon, T, Azulay, JP, Guedj, E et al.. 18F-FDG brain PET: a metabolic predictive factor for gait improvement after cerebrospinal fluid shunting in normal pressure hydrocephalus?. Q J Nucl Med Mol Imaging. 2024;68 (3):179-186. doi: 10.23736/S1824-4785.24.03582-9. PubMed PMID:39295448 .